The TTN gene is frequently mutated in a variety of tumor types, and frequent detection of TTN in solid tumors is related to a higher tumor mutation burden and a more favorable objective response to immune checkpoint blockade immunotherapy [55]. This evidence concerns the gene TTN and neoplasm.